|
Catalog# |
BRP1203-1 |
|---|---|
|
Lot # |
Check on the product label |
|
Size |
10 μg |
|
Description |
Recombinant mouse GM-CSF is produced by the E.coli system, with the target gene encoding Ala18-Lys141 expressed. |
|
Synonyms |
CSF2, GMCSF, colony stimulating factor 2, CSF |
|
Source |
E.coli |
|
Uniprot No. |
P01587 |
|
Purity |
>95% by SDS-PAGE |
|
Endotoxin level |
<0.01 EU/µg by LAL test |
|
Formulation |
Lyophilized from a 0.2 μm filtered solution of 20mM Tris-HCl,1mM EDTA,4%Mannitol,pH 8.0. |
|
Reconstitution |
Dissolve the lyophilized protein in distilled water (It is not recommended to reconstitute to a concentration <100 μg/ml.) |
|
Application |
SDS-PAGE Other applications have not been tested. The optimal dilutions should be determined by end user. |
|
Storage& Expiration |
Ship at 4℃. Upon receipt, aliquot and store at -20℃ or -80℃ for long term. Avoid repeated freeze and thaw cycles. |
|
Background |
Granulocyte-macrophage colony- stimulating factor (GM-CSF), also known as colony-stimulating factor 2 (CSF2), is a monomeric glycoprotein secreted by macrophages, T cells, mast cells, natural killer cells, endothelial cells and fibroblasts that functions as a cytokine. The pharmaceutical analogs of naturally occurring GM-CSF are called sargramostim and molgramostim. Unlike granulocyte colony-stimulating factor, which specifically promotes neutrophil proliferation and maturation, GM-CSF affects more cell types, especially macrophages and eosinophils. |
|
Reference |
1. Root RK, Dale DC (March 1999). "Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor: comparisons and potential for use in the treatment of infections in nonneutropenic patients". The Journal of Infectious Diseases. 179 (Suppl 2): S342-52. |

Details
Product Center
